NASDAQ Top Percentage Gainers: CLUB, AXTI, DVAX, GMCR
POINT ROBERTS, July 29, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for July 28, 2011. On Thursday, Town Sports International was in spotlight as the stock climbed 24.25%.
Town Sports International Holdings, Inc. (NASDAQ:CLUB) was the biggest gaineron Nasdaq and soared $1.85 (24.25%) to $9.48 and made a new 52-week high of $9.88. The company reported 16 cents a share with revenue growing 0.70% to $118.285 million in second quarter.
AXT, Inc. (NASDAQ:AXTI) climbed $1.49 (20.55%) to $8.74. Analysts at Needham & Company upgraded shares of AXT, Inc. (NASDAQ: AXTI) from a "hold" rating to a "buy" rating in a research note to investors and has an $11.00 price target on the stock.
Dynavax Technologies Corporation (NASDAQ:DVAX) gained $0.41 (16.87%) to $2.84 after it disclosed the U.S. Food and Drug Administration agreed with the biopharmaceutical company's clinical findings related to a vaccine for adult hepatitis B.
Dynavax said the FDA found that while the manufactured lots of heplisav didn't meet pre-specified time point of four weeks post the last dose, it met the eight week criteria, as well as several other time points.
Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) moved $14.46 (16.41%) to $102.57 and made an all-time high of $107.27. The company said that it had a profit of $56.3 million, or 37 cents a share, compared to a year ago profit of $18.4 million, or 13 cents a share, a year earlier. On an adjusted basis, the company earned 49 cents a share, topping analysts’ estimates by 12 cents a share.
Revenue 126.50% to $717.21 million from $316.58 million in the year-ago quarter, ahead of analysts’ estimates of $606.76 million.
Gross margin also improved to 36.8% from 34.4%.
Investorideas.com Free Investor Tools;
Sign up for the free investor news and stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com
Friday, July 29, 2011
Thursday, July 28, 2011
Clean Energy Stocks Trading Alert; (NASDAQ: BWEN), (OTCBB: CWET), (NASDAQ FSLR), (NYSE: SOL)
Point Roberts, WA - July 28, 2011 - Investorideas.com, a leader in cleantech stock research, reports on wind and solar stocks trading for July 27th. US markets are seeing gains this morning in early trading with NADAQ and the DOW both in the positive. Investors following volatile solar stocks are seeing some gains in some of the sector leaders this morning.
Wind and Solar Stocks Trading July28th
Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office, a patent application titled "Advanced Construction Using Precision Adjustment, Joining and Strengthening Techniques."
The patent application describes and claims exclusive rights to an innovative building system and method that allows very strong and long-lasting structures to be built to standards of accuracy usually associated with precision machining. This technology is key to building large and rugged structures that will endure the everyday stresses and environmental variations prevalent over periods estimated to exceed fifty years.
Ronald W. Pickett, Chairman and CEO, stated, "These innovative precision building techniques are significant, and coupled with our building architecture matrix of strong lightweight interlaced structural members, will provide multiple benefits to Clean Wind Energy's Dual Renewable Energy solution, differentiating it as an extremely viable alternative energy project."
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Wind Company Snapshot
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large " Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology. www.cleanwindenergytower.com
Clean Wind Energy, Inc. Contact:
1997 Annapolis Exchange Parkway Suite 300
Annapolis , Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
Visit the CWET showcase page at Investorideas.com : http://www.investorideas.com/CO/CWE/
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on wind stocks
http://www.investorideas.com/Resources/Newsletter.asp
Follow Investorideas.com on Twitterhttp://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebookhttp://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Point Roberts, WA - July 28, 2011 - Investorideas.com, a leader in cleantech stock research, reports on wind and solar stocks trading for July 27th. US markets are seeing gains this morning in early trading with NADAQ and the DOW both in the positive. Investors following volatile solar stocks are seeing some gains in some of the sector leaders this morning.
Wind and Solar Stocks Trading July28th
- Broadwind Energy, Inc. (NasdaqGS: BWEN ) trading up at $1.30, up 0.05 (4.00%) 10:41AM EDT
- China Ming Yang Wind Power Group (NYSE: MY ) trading up at $5.21, up 0.02 (0.39%)
- Clean Wind Energy Tower, Inc. (OTCBB: CWET) trading at $0.19.
- First Solar, Inc.(NasdaqGS: FSLR ) trading at $117.91, up 1.31 (1.12%) 10:43AM EDT
- LDK Solar (NYSE: LDK ) trading up at $6.63, up 0.01 (0.15%) 10:45AM EDT
- Renesola Ltd. (NYSE: SOL ) trading up at $ 4.62, gaining 0.13 (2.90%) 10:47AM EDT
Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office, a patent application titled "Advanced Construction Using Precision Adjustment, Joining and Strengthening Techniques."
The patent application describes and claims exclusive rights to an innovative building system and method that allows very strong and long-lasting structures to be built to standards of accuracy usually associated with precision machining. This technology is key to building large and rugged structures that will endure the everyday stresses and environmental variations prevalent over periods estimated to exceed fifty years.
Ronald W. Pickett, Chairman and CEO, stated, "These innovative precision building techniques are significant, and coupled with our building architecture matrix of strong lightweight interlaced structural members, will provide multiple benefits to Clean Wind Energy's Dual Renewable Energy solution, differentiating it as an extremely viable alternative energy project."
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Wind Company Snapshot
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large " Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology. www.cleanwindenergytower.com
Clean Wind Energy, Inc. Contact:
1997 Annapolis Exchange Parkway Suite 300
Annapolis , Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
Visit the CWET showcase page at Investorideas.com : http://www.investorideas.com/CO/CWE/
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on wind stocks
http://www.investorideas.com/Resources/Newsletter.asp
Follow Investorideas.com on Twitterhttp://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebookhttp://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Visit the CWET showcase page at Investorideas.com:
http://www.investorideas.com/CO/CWE/
http://www.investorideas.com/CO/CWE/
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com and our Green Investor content:http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on wind stocks
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asphttp://www.investorideas.com/Resources/Newsletter.asp
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Biotech Stock Trading News; (OTCBB:AEMD), (NASDAQ:QCOR) ,
(NASDAQ:MSHL), (NASDAQ:GILD)
Point Roberts, WA - July 28, 2011 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for July 27, 2011. Top gaining stocks in the sector included oncology stock, Marshall Edwards, Inc. (NASDAQ:MSHL) with a gain of over 135%.
Biotech/Pharma Sector Snapshot Trading July 27 th
Aethlon Medical (OTCBB: AEMD) closed at $0.0890. The Company’s primary technology, Hemopurifier®, is a device that has demonstrated broad-spectrum activity against infectious viral pathogens, immunosuppressive proteins and exosomes secreted by cancer. Increasingly, exosomes are being discovered to have implications in other life-threatening diseases.
On July 19 th the company met with FDA officials to discuss a proposed clinical program to support the regulatory advancement of the Hemopurifier® as a treatment countermeasure against bioterror and pandemic threats. Based on data collected from clinical programs conducted in India, AEMD will also seek permission from the FDA to expand treatment indications to include Hepatitis C virus (HCV). Formal FDA feedback to next week's meeting would likely occur in early fall.
Marshall Edwards, Inc. (NASDAQ:MSHL) gained $1.58 (135.04%) to $2.75 after it announced the publication of results from a pre-clinical study of NV-128 showing activity in chemotherapy-resistant ovarian cancer stem cells. NV-128 is the prodrug of the Company's investigational compound and lead mitochondrial inhibitor drug candidate, NV-344. Marshall Edwards, Inc. (NASDAQ:MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics.
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) climbed $6.50 (25.00%) to $32.50 and made a new 52-week high of $32.78 the Company reported second quarter results. Net sales increased 62% year over year to $46.0 million. Net income for the quarter was $13.9 million or $0.21 per diluted share compared to $9.3 million or $0.14 per diluted common share in the second quarter of 2010.
Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) shares also climbed 0.014 (7.38%) to $0.209, rebounding from its 52-week low of $0.18 made earlier this week. So far this year, the stock is down about 66%. It has a 52-week range of $0.18-$0.75.
OXiGENE, Inc. (NASDAQ:OXGN ) climbed 0.05 (2.56%) to $2.00 on high volume. So far this year, the stock is down about 58%. It has a 52-week range of $1.52-$11.00.
Gilead Sciences, Inc. (NASDAQ:GILD) added 0.81 (1.92%) to $42.97. The company reported total revenues of $2.14bn for the second quarter ended 30 June 2011, an increase of 11% as compared to $1.93bn for the same period in 2010.
Gilead Sciences' net income was $746.23m, compared to $712.06m for the same period in the prior year.
Biotech Medical Company Snapshot for Aethlon Medical (OTCBB: AEMD)
Visit the AEMD showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
1.Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2.Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3.Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4.Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings .
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
(NASDAQ:MSHL), (NASDAQ:GILD)
Point Roberts, WA - July 28, 2011 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for July 27, 2011. Top gaining stocks in the sector included oncology stock, Marshall Edwards, Inc. (NASDAQ:MSHL) with a gain of over 135%.
Biotech/Pharma Sector Snapshot Trading July 27 th
Aethlon Medical (OTCBB: AEMD) closed at $0.0890. The Company’s primary technology, Hemopurifier®, is a device that has demonstrated broad-spectrum activity against infectious viral pathogens, immunosuppressive proteins and exosomes secreted by cancer. Increasingly, exosomes are being discovered to have implications in other life-threatening diseases.
On July 19 th the company met with FDA officials to discuss a proposed clinical program to support the regulatory advancement of the Hemopurifier® as a treatment countermeasure against bioterror and pandemic threats. Based on data collected from clinical programs conducted in India, AEMD will also seek permission from the FDA to expand treatment indications to include Hepatitis C virus (HCV). Formal FDA feedback to next week's meeting would likely occur in early fall.
Marshall Edwards, Inc. (NASDAQ:MSHL) gained $1.58 (135.04%) to $2.75 after it announced the publication of results from a pre-clinical study of NV-128 showing activity in chemotherapy-resistant ovarian cancer stem cells. NV-128 is the prodrug of the Company's investigational compound and lead mitochondrial inhibitor drug candidate, NV-344. Marshall Edwards, Inc. (NASDAQ:MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics.
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) climbed $6.50 (25.00%) to $32.50 and made a new 52-week high of $32.78 the Company reported second quarter results. Net sales increased 62% year over year to $46.0 million. Net income for the quarter was $13.9 million or $0.21 per diluted share compared to $9.3 million or $0.14 per diluted common share in the second quarter of 2010.
Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) shares also climbed 0.014 (7.38%) to $0.209, rebounding from its 52-week low of $0.18 made earlier this week. So far this year, the stock is down about 66%. It has a 52-week range of $0.18-$0.75.
OXiGENE, Inc. (NASDAQ:OXGN ) climbed 0.05 (2.56%) to $2.00 on high volume. So far this year, the stock is down about 58%. It has a 52-week range of $1.52-$11.00.
Gilead Sciences, Inc. (NASDAQ:GILD) added 0.81 (1.92%) to $42.97. The company reported total revenues of $2.14bn for the second quarter ended 30 June 2011, an increase of 11% as compared to $1.93bn for the same period in 2010.
Gilead Sciences' net income was $746.23m, compared to $712.06m for the same period in the prior year.
Biotech Medical Company Snapshot for Aethlon Medical (OTCBB: AEMD)
Visit the AEMD showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
1.Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2.Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3.Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4.Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings .
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Nanotechnology Stock News; mPhase (OTC.BB:XDSL) Announces Letter of Intent to Acquire Energy Innovative Products, Inc.
LITTLE FALLS, NJ - July 28, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL) today announced it has entered into a letter of intent (LOI) to acquire Energy Innovative Products, Inc. (EIP), a developer of proprietary technologies for reducing energy usage in refrigeration and cooling systems, as well as equipment utilizing AC induction motors. EIP, based in Fairfield, NJ, uses patented and patent pending solutions to offer a series of products that control voltage and current used by compressor systems, including those in refrigeration decks, HVAC wall units, commercial refrigeration systems, and consumer equipment. The company, founded in 2008, believes its technology is uniquely positioned to capitalize on each of these multi-billion dollar market opportunities by allowing legacy systems to achieve Energy Star status as well as compliance with emerging standards by the UnitedStates
Department of Energy (DOE) and other regulatory bodies.
In the UnitedStates alone, there are several million legacy refrigerated vending machines used by major beverage companies. EIP's solution is the only company certified for Energy Star status and able to deliver over a 50% reduction in power consumption by machines such as the Dixie Narco 501 without reducing efficiency or cooling and without requiring a change-out in the unit's refrigeration deck. Governmental and power company rebates are available to support the purchase of EIP's products in several states. According to Scott Caputo, President of EIP, "Corporate demand for energy saving solutions is increasing worldwide driven by rising fuel costs, skyrocketing electricity costs, and growing concerns about greenhouse gases and their impact on our world's environment."
The terms of the deal include the issuance of common shares and warrants for an 81% stake in EIP. "We are extremely excited about the upside EIP offers to our organization over the coming years," said Ron Durando, CEO of mPhase Technologies, Inc. The transaction is expected to become a Definitive Agreement in August 2011 and close by October 2011. EIP is being advised on the transaction by Source Capital Group, Inc., a boutique investment banking firm focused on emerging growth companies and based in Westport, CT. Said Vik Grover, CFA, Senior Managing Director at SCG, "We expect the transaction to be significantly accretive to mPhase shareholders in 2012-2013 and EIP to become a market leader in the energy management space."
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
About Energy Innovative Products, Inc.
EIP's mission is to develop, commercialize and market technology for reducing energy usage in refrigeration and cooling systems as well as equipment utilizing AC induction motors. We have developed a small, easy to install single-phase motor controller device designed for both commercial and consumer use that reduces electrical consumption and peak demand usage in refrigerators, freezers, vending machines and other similar appliances. We have also designed a kit containing an electronic evaporator motor and high tech dimmable LED lights that is used to upgrade vending machines and coolers to Energy Star compliance. More information about the Company can be found at www.eipsave.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
LITTLE FALLS, NJ - July 28, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL) today announced it has entered into a letter of intent (LOI) to acquire Energy Innovative Products, Inc. (EIP), a developer of proprietary technologies for reducing energy usage in refrigeration and cooling systems, as well as equipment utilizing AC induction motors. EIP, based in Fairfield, NJ, uses patented and patent pending solutions to offer a series of products that control voltage and current used by compressor systems, including those in refrigeration decks, HVAC wall units, commercial refrigeration systems, and consumer equipment. The company, founded in 2008, believes its technology is uniquely positioned to capitalize on each of these multi-billion dollar market opportunities by allowing legacy systems to achieve Energy Star status as well as compliance with emerging standards by the United
In the United
The terms of the deal include the issuance of common shares and warrants for an 81% stake in EIP. "We are extremely excited about the upside EIP offers to our organization over the coming years," said Ron Durando, CEO of mPhase Technologies, Inc. The transaction is expected to become a Definitive Agreement in August 2011 and close by October 2011. EIP is being advised on the transaction by Source Capital Group, Inc., a boutique investment banking firm focused on emerging growth companies and based in Westport, CT. Said Vik Grover, CFA, Senior Managing Director at SCG, "We expect the transaction to be significantly accretive to mPhase shareholders in 2012-2013 and EIP to become a market leader in the energy management space."
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
About Energy Innovative Products, Inc.
EIP's mission is to develop, commercialize and market technology for reducing energy usage in refrigeration and cooling systems as well as equipment utilizing AC induction motors. We have developed a small, easy to install single-phase motor controller device designed for both commercial and consumer use that reduces electrical consumption and peak demand usage in refrigerators, freezers, vending machines and other similar appliances. We have also designed a kit containing an electronic evaporator motor and high tech dimmable LED lights that is used to upgrade vending machines and coolers to Energy Star compliance. More information about the Company can be found at www.eipsave.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
NASDAQ Winners July 27th; NVGN, ACXM, IACI
Oncology Company, Marshall Edwards, Inc Gains over 135%
POINT ROBERTS, July 28, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for July 27, 2011. Thursday, Oncology Company, Marshall Edwards, Inc topped the market winners with a gain of over 135%.
Marshall Edwards, Inc. (NASDAQ:MSHL) spiked $1.58 (135.04%) to $2.75 after it announced the publication of results from a pre-clinical study of NV-128 showing activity in chemotherapy-resistant ovarian cancer stem cells. NV-128 is the prodrug of the Company's investigational compound and lead mitochondrial inhibitor drug candidate, NV-344.
Novogen Limited (ADR) (Public, NASDAQ:NVGN) climbed $0.41 (46.07%) to $1.30. Last week, the company announced it has entered into an agreement for the sale of its consumer products division. The sale remains subject to certain conditions but is expected to close within the next 60 days. The buyer and terms of the agreement were not disclosed.
Acxiom Corporation (NASDAQ:ACXM) gained $2.14 (18.07%) to $13.98 after the company announced that its Board of Directors has named marketing and advertising veteran Scott E. Howe as the company’s chief executive officer and president.
IAC/InterActiveCorp (NASDAQ:IACI) surged $4.25 (11.25%) to $42.04. The Company reported a second-quarter profit of 62 cents a share after excluding special items. Analysts on average expected 40 cents a share.
Revenue, including subscriptions at IAC's online personals sites like Match.com and Chemistry.com, rose 23 percent to $485.4 million. Analysts had forecast $463.4 million.
Investorideas.com Free Investor Tools;
Sign up for the free investor news and stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Retails Companies Reporting Same-Store Sales (ZUMZ, HOTT, M, LTD, CATO)
Retail Stocks In Focus (DDS, JCP, KSS, JWN, ROST)
Top Gainers (APAC, MCZ, OCZ, RENN, PMI)
Top Losers (AFFX, LL, FST, YMI, AIB)
Stocks To Watch (TGT, REDF, DANG, MOBI, SODA)
Oncology Company, Marshall Edwards, Inc Gains over 135%
POINT ROBERTS, July 28, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for July 27, 2011. Thursday, Oncology Company, Marshall Edwards, Inc topped the market winners with a gain of over 135%.
Marshall Edwards, Inc. (NASDAQ:MSHL) spiked $1.58 (135.04%) to $2.75 after it announced the publication of results from a pre-clinical study of NV-128 showing activity in chemotherapy-resistant ovarian cancer stem cells. NV-128 is the prodrug of the Company's investigational compound and lead mitochondrial inhibitor drug candidate, NV-344.
Novogen Limited (ADR) (Public, NASDAQ:NVGN) climbed $0.41 (46.07%) to $1.30. Last week, the company announced it has entered into an agreement for the sale of its consumer products division. The sale remains subject to certain conditions but is expected to close within the next 60 days. The buyer and terms of the agreement were not disclosed.
Acxiom Corporation (NASDAQ:ACXM) gained $2.14 (18.07%) to $13.98 after the company announced that its Board of Directors has named marketing and advertising veteran Scott E. Howe as the company’s chief executive officer and president.
IAC/InterActiveCorp (NASDAQ:IACI) surged $4.25 (11.25%) to $42.04. The Company reported a second-quarter profit of 62 cents a share after excluding special items. Analysts on average expected 40 cents a share.
Revenue, including subscriptions at IAC's online personals sites like Match.com and Chemistry.com, rose 23 percent to $485.4 million. Analysts had forecast $463.4 million.
Investorideas.com Free Investor Tools;
Sign up for the free investor news and stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source – Investorideas.com
Retails Companies Reporting Same-Store Sales (ZUMZ, HOTT, M, LTD, CATO)
Retail Stocks In Focus (DDS, JCP, KSS, JWN, ROST)
Top Gainers (APAC, MCZ, OCZ, RENN, PMI)
Top Losers (AFFX, LL, FST, YMI, AIB)
Stocks To Watch (TGT, REDF, DANG, MOBI, SODA)
Biotech and Pharma News; BioSante Pharmaceuticals (NASDAQ : BPAX) Prices Public Offering of Common Stock
LINCOLNSHIRE, Ill. - July 28, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced the pricing of its previously announced underwritten public offering of 16.0 million shares of its common stock, offered at a price of $3.00 per share to the public. The net proceeds to BioSante from this offering are expected to be approximately $45.0 million, after deducting underwriting discounts and commissions, and other estimated offering expenses payable by BioSante. All of the shares in the offering are to be sold by BioSante. The offering is expected to close on or about August 2, 2011, subject to the satisfaction of customary closing conditions. BioSante has granted the underwriters a 30-day option to purchase up to an aggregate of 2.4 million additional shares of common stock to cover over-allotments, if any.
Jefferies & Company, Inc. is acting as the sole book-running manager for the offering. Rodman & Renshaw, LLC, JMP Securities LLC and Roth Capital Partners, LLC are acting as co-managers for the offering.
A shelf registration statement on Form S-3 relating to the public offering of the shares of common stock described above was filed with the Securities and Exchange Commission (SEC) and is effective. A preliminary prospectus supplement relating to the offering has been filed with the SEC and a final prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC�s website at www.sec.gov. When available, copies of the final prospectus supplement may also be obtained from the offices of Jefferies & Company, Inc., Equity Syndicate Prospectus Department, at 520 Madison Avenue, 12th Floor, New York, NY 10022, at 877-547-6340 and at Prospectus_Department@Jefferies.com.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to the completion and timing of the public offering and the amount of net proceeds to be received. Such statements are identified by words such as �expect,� �intend,� "will," �may,� "continue," "could," "believe," �anticipate," and other words of similar meaning, derivations of such words or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, risks and uncertainties related to market and other conditions and the satisfaction of customary closing conditions related to the public offering. There can be no assurance that BioSante will be able to complete the public offering on the anticipated terms, or at all. Additional risks and uncertainties related to the public offering, BioSante and its business are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly report on Form 10-Q and in the preliminary prospectus supplement related to the proposed offering filed with the SEC and in the final prospectus supplement related to the offering to be filed with the SEC on or about the date hereof. All forward-looking statements in this release speak only as of the date of this release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and onlineadvertising .
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com
LINCOLNSHIRE, Ill. - July 28, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced the pricing of its previously announced underwritten public offering of 16.0 million shares of its common stock, offered at a price of $3.00 per share to the public. The net proceeds to BioSante from this offering are expected to be approximately $45.0 million, after deducting underwriting discounts and commissions, and other estimated offering expenses payable by BioSante. All of the shares in the offering are to be sold by BioSante. The offering is expected to close on or about August 2, 2011, subject to the satisfaction of customary closing conditions. BioSante has granted the underwriters a 30-day option to purchase up to an aggregate of 2.4 million additional shares of common stock to cover over-allotments, if any.
Jefferies & Company, Inc. is acting as the sole book-running manager for the offering. Rodman & Renshaw, LLC, JMP Securities LLC and Roth Capital Partners, LLC are acting as co-managers for the offering.
A shelf registration statement on Form S-3 relating to the public offering of the shares of common stock described above was filed with the Securities and Exchange Commission (SEC) and is effective. A preliminary prospectus supplement relating to the offering has been filed with the SEC and a final prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC�s website at www.sec.gov. When available, copies of the final prospectus supplement may also be obtained from the offices of Jefferies & Company, Inc., Equity Syndicate Prospectus Department, at 520 Madison Avenue, 12th Floor, New York, NY 10022, at 877-547-6340 and at Prospectus_Department@Jefferies.com.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to the completion and timing of the public offering and the amount of net proceeds to be received. Such statements are identified by words such as �expect,� �intend,� "will," �may,� "continue," "could," "believe," �anticipate," and other words of similar meaning, derivations of such words or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, risks and uncertainties related to market and other conditions and the satisfaction of customary closing conditions related to the public offering. There can be no assurance that BioSante will be able to complete the public offering on the anticipated terms, or at all. Additional risks and uncertainties related to the public offering, BioSante and its business are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly report on Form 10-Q and in the preliminary prospectus supplement related to the proposed offering filed with the SEC and in the final prospectus supplement related to the offering to be filed with the SEC on or about the date hereof. All forward-looking statements in this release speak only as of the date of this release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com
Wednesday, July 27, 2011
Wind Stock; Clean Wind Energy Tower, Inc. (OTCBB: CWET) Files Patent for "Advanced Construction Using Precision Adjustment, Joining and Strengthening Techniques"
ANNAPOLIS, MD � July 27, 2011 (InvestorIdeas.com Newswire) � Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office, a patent application titled "Advanced Construction Using Precision Adjustment, Joining and Strengthening Techniques."
The patent application describes and claims exclusive rights to an innovative building system and method that allows very strong and long-lasting structures to be built to standards of accuracy usually associated with precision machining. This technology is key to building large and rugged structures that will endure the everyday stresses and environmental variations prevalent over periods estimated to exceed fifty years.
Ronald W. Pickett, Chairman and CEO, stated, "These innovative precision building techniques are significant, and coupled with our building architecture matrix of strong lightweight interlaced structural members, will provide multiple benefits to Clean Wind Energy's Dual Renewable Energy solution, differentiating it as an extremely viable alternative energy project."
About Clean Wind Energy, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Clean Wind Energy, Inc. Contact:
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
Investor Relations Contact:
Jody Janson
Phone: (855) 848-6937
Email: ir@cwetower.com
Public Relations Contact:
Michael J. Porter, President,
Porter, LeVay & Rose, Inc.
mike@plrinvest.com,
(212) 564-4700
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
ANNAPOLIS, MD � July 27, 2011 (InvestorIdeas.com Newswire) � Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office, a patent application titled "Advanced Construction Using Precision Adjustment, Joining and Strengthening Techniques."
The patent application describes and claims exclusive rights to an innovative building system and method that allows very strong and long-lasting structures to be built to standards of accuracy usually associated with precision machining. This technology is key to building large and rugged structures that will endure the everyday stresses and environmental variations prevalent over periods estimated to exceed fifty years.
Ronald W. Pickett, Chairman and CEO, stated, "These innovative precision building techniques are significant, and coupled with our building architecture matrix of strong lightweight interlaced structural members, will provide multiple benefits to Clean Wind Energy's Dual Renewable Energy solution, differentiating it as an extremely viable alternative energy project."
About Clean Wind Energy, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Clean Wind Energy, Inc. Contact:
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
Investor Relations Contact:
Jody Janson
Phone: (855) 848-6937
Email: ir@cwetower.com
Public Relations Contact:
Michael J. Porter, President,
Porter, LeVay & Rose, Inc.
mike@plrinvest.com,
(212) 564-4700
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Visit the CWET showcase page at Investorideas.com:
http://www.investorideas.com/CO/CWE/
http://www.investorideas.com/CO/CWE/
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com and our Green Investor content:http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on wind stocks
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asphttp://www.investorideas.com/Resources/Newsletter.asp
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Gold and Mining Stocks News; Lomiko (TSX-V: LMR; OTC: LMRMF) Adds 414 Ha to Vines Lake Property
Vancouver, BC - July 27, 2011 (Investorideas.com mining stocks newswire) � LOMIKO METALS INC. (TSX-V:LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7) has staked an additional 414 Ha directly west of the Vines Lake claims. Lomiko now holds the rights to four contiguous mineral tenures, totaling 1,583 Ha located in the southwestern corner of the Cassiar District or 'Cassiar Camp'.
Due to the property's close proximity to formerly producing mines with a proven history in the Cassiar Mining Camp, it is the opinion of the Company that potential exists on the 100% owned Vines Lake Property for discovering new high-grade gold vein systems. Also, there is a potential for other intrusion related mineralization in proximity to the Cassiar Batholith and its associated boundary contacts, over which Lomiko's Vines Lake property claims are located.
Cassiar Area Highlights:
On behalf of Lomiko Metals Inc,
A. Paul Gill, President & CEO
We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
647-607-6023
Bay Street Connect
info@lomiko.com
Lomiko Metals Inc.
www.lomiko.com
Vancouver, BC - July 27, 2011 (Investorideas.com mining stocks newswire) � LOMIKO METALS INC. (TSX-V:LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7) has staked an additional 414 Ha directly west of the Vines Lake claims. Lomiko now holds the rights to four contiguous mineral tenures, totaling 1,583 Ha located in the southwestern corner of the Cassiar District or 'Cassiar Camp'.
Due to the property's close proximity to formerly producing mines with a proven history in the Cassiar Mining Camp, it is the opinion of the Company that potential exists on the 100% owned Vines Lake Property for discovering new high-grade gold vein systems. Also, there is a potential for other intrusion related mineralization in proximity to the Cassiar Batholith and its associated boundary contacts, over which Lomiko's Vines Lake property claims are located.
Cassiar Area Highlights:
- A new company with Chinese investors known as
China Minerals Mining Corporation is located adjacent to the property. - A fully permitted 270 tonne per day, gravity and flotation mill, power plant, assay laboratory and tailings impoundment facility is owned by China Minerals.
- Approximately 316,000 ounces of gold have been produced at the adjacent Table Mountain Mine from 1979-2007 under various companies.
- Current Resource Estimates for the Table Mountain Mine are 21,471 tonnes grading 18.02 g/t indicated and 65,757 tonnes grading 24.3 g/t inferred were reported at the adjacent property in the May, 2010 NI43-101 Technical Report on the Table Mountain Property by C. Pearson and F.J. Bakker.
- Two significant anomalies have been identified by geophysical surveys. The claims cover formations of the Sylvester group, which are known to contain productive zones of gold mineralization in the area.
- The Vines Lake Property is located approximately two kilometres southwest of the former Erickson gold mine.
- Highway 37 N bisects the property north to south providing excellent year-round access.
On behalf of Lomiko Metals Inc,
A. Paul Gill, President & CEO
We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
647-607-6023
Bay Street Connect
info@lomiko.com
Lomiko Metals Inc.
www.lomiko.com
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. Lomiko Metals Inc. (TSX-V: LMR) three month showcase gold stock on Investorideas.com and all related mining portals and blogs (one thousand per month)
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stocklists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising .
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Iron Ore Stocks Investor News Alert; (OTCBB:TRKP), FEO, BKI, AXI
PointRoberts WA - July 27 2011 (Investorideas.com Mining Newswire) � www.Investorideas.com, a leader in sector research for investors including mining and resource stocks, issues a trading alert for iron ore stocks, as of trading July 26th.
For investors following iron ore stocks, the China Iron & Steel Association (CISA), is in stages of getting approval to publish an iron ore index. Since China is one of the largest driving factors in the sector, the data will be critical to investors .
http://www.chinaisa.org.cn/index.php
TurkPower Corporation (OTC:TRKP) shares ended flat to $0.30. On Tuesday, the company announced the signing of a cooperation agreement between its subsidiary Maksor Madencilik Sanayi Ve Ticaret Anonim Sirketi (hereafter "Maxore") with the Austrian beneficiation plant manufacturer.
Oceanic Iron Ore Corp (CVE:FEO) closed with a gain of 2.50% to $0.40. The company announced the appointment of SGS in Lakefield to conduct bench scale metallurgical testing, including head assays, Wilfley table gravity testing and Davis tube testing, on some 800 samples from the Company's Hopes Advance Bay project.
BLACK IRON INC COM NPV ( Toronto: BKI.TO ) surged 0.92% to $28.49. The company is schedule a conference call for Wednesday, August 3, 2011 at 10:00 a.m. Central (11:00 Eastern) to discuss fourth quarter and fiscal year 2011 results.
Advanced Explorations Inc (CVE:AXI) rose 1.03% to $0.49. The company updated progress on its metallurgical test work completed on the A/B Zone of its Roche Bay Iron Project. The A/B Zone is located on strike with the Company's Roche Bay Project C-Zone on the east coast of the Melville Peninsula in Nunavut, Canada.
Iron Ore Stocks Snapshot:
TurkPower Corporation (OTCBB:TRKP) is a Turkish-American junior mining company that is acquiring controlling ownership in an operational iron ore mine and several mining projects under development in Turkey. TurkPower's sole focus is on the booming Turkish mining industry, where it aims to become a leader in developing, operating and owning base metal mines by acquiring and consolidating operational mines with proven reserves, utilizing economies of scale to increase returns as well as developing new mining assets. TurkPower's board ofdirectors , management team and employees have extensive experience and relations in the Turkish mining industry, as well as ongoing relations with the relevant government agencies, allowing TurkPower to participate in the major opportunities currently developing in Turkey.
Visit the company profile at Investorideas.com
http://www.investorideas.com/CO/TRKP/
Sign up for news on TRKP and other mining stocks
http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sectors. Sectors we cover include; water stocks, gold and mining stocks, China stocks, oil and gas stocks, renewable energy stocks, coal stocks, tech stocks, biotech stocks, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. TRKP is a paid advertising client ( three thousand five hundred per month, 150,000 144 shares) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Point
For investors following iron ore stocks, the China Iron & Steel Association (CISA), is in stages of getting approval to publish an iron ore index. Since China is one of the largest driving factors in the sector, the data will be critical to investors .
http://www.chinaisa.org.cn/index.php
TurkPower Corporation (OTC:TRKP) shares ended flat to $0.30. On Tuesday, the company announced the signing of a cooperation agreement between its subsidiary Maksor Madencilik Sanayi Ve Ticaret Anonim Sirketi (hereafter "Maxore") with the Austrian beneficiation plant manufacturer.
Oceanic Iron Ore Corp (CVE:FEO) closed with a gain of 2.50% to $0.40. The company announced the appointment of SGS in Lakefield to conduct bench scale metallurgical testing, including head assays, Wilfley table gravity testing and Davis tube testing, on some 800 samples from the Company's Hopes Advance Bay project.
BLACK IRON INC COM NPV ( Toronto: BKI.TO ) surged 0.92% to $28.49. The company is schedule a conference call for Wednesday, August 3, 2011 at 10:00 a.m. Central (11:00 Eastern) to discuss fourth quarter and fiscal year 2011 results.
Advanced Explorations Inc (CVE:AXI) rose 1.03% to $0.49. The company updated progress on its metallurgical test work completed on the A/B Zone of its Roche Bay Iron Project. The A/B Zone is located on strike with the Company's Roche Bay Project C-Zone on the east coast of the Melville Peninsula in Nunavut, Canada.
Iron Ore Stocks Snapshot:
- Mechel OAO (ADR) (NYSE:MTL) jumped 1.75% to $25.62.
- Champion Minerals Inc. (TSE:CHM) ended lower by 5.14% to $1.66.
- Labrador Iron Mines Holdings Limited (TSE:LIM) fell 2.30% to $11.49.
- Adriana Resources Inc. (CVE:ADI) fell 3.03% to $0.96.
TurkPower Corporation (OTCBB:TRKP) is a Turkish-American junior mining company that is acquiring controlling ownership in an operational iron ore mine and several mining projects under development in Turkey. TurkPower's sole focus is on the booming Turkish mining industry, where it aims to become a leader in developing, operating and owning base metal mines by acquiring and consolidating operational mines with proven reserves, utilizing economies of scale to increase returns as well as developing new mining assets. TurkPower's board of
Visit the company profile at Investorideas.com
http://www.investorideas.com/CO/TRKP/
Sign up for news on TRKP and other mining stocks
http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sectors. Sectors we cover include; water stocks, gold and mining stocks, China stocks, oil and gas stocks, renewable energy stocks, coal stocks, tech stocks, biotech stocks, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. TRKP is a paid advertising client ( three thousand five hundred per month, 150,000 144 shares) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Nanotechnology Stock News; mPhase (OTC.BB:XDSL) Completes 2nd Prototype of New Automotive Product Using Advanced Battery Technology
LITTLE FALLS, NJ - July 27, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL) today said that it has completed its 2nd working prototype of a new automotive and marine product.
"In less than 60 days we have produced a refined product with a 20% reduction in size and increased functionality," said Ronald A. Durando, CEO of mPhase Technologies, Inc.
Working together with a renowned European automobile manufacturer, mPhase has developed this new product which features advanced battery technology, which is expected to have broad appeal to both the OEM and aftermarket automotive and marine industry.
The company continues to keep the new product under wraps in order to protect their intellectual property from being reverse engineered.
mPhase also said that it has begun to focus on strategic acquisitions which it believes can bring immediate value to the company.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
LITTLE FALLS, NJ - July 27, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL) today said that it has completed its 2nd working prototype of a new automotive and marine product.
"In less than 60 days we have produced a refined product with a 20% reduction in size and increased functionality," said Ronald A. Durando, CEO of mPhase Technologies, Inc.
Working together with a renowned European automobile manufacturer, mPhase has developed this new product which features advanced battery technology, which is expected to have broad appeal to both the OEM and aftermarket automotive and marine industry.
The company continues to keep the new product under wraps in order to protect their intellectual property from being reverse engineered.
mPhase also said that it has begun to focus on strategic acquisitions which it believes can bring immediate value to the company.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Energy Stocks News; American Petro-Hunter (OTCBB: AAPH) Outlines Drilling Campaign in North Oklahoma
SCOTTSDALE, AZ � July 27, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to provide an outline of plans for the next two wells to be drilled at the Company's field development program at the North Oklahoma Project. These next wells in the series have been designated as NOS-2-22 and NOW-2H.
Preparations are now underway to commence drilling of the NOS-2-22 well with a scheduled spud date in approximately 2 weeks. The well is a direct offset to the producing NOS-1-22 well and has been engineered as a 3,500 foot vertical to exploit the productive oil bearing sand formation discovered in previous drilling. This is the first of potentially 3 offsets planned on this particular lease. With production facilities already in place, the drilling is hoped to add an additional 50 BPOD net to the Company by September. An exact spud date will be announced shortly.
The NOW-2H is scheduled as the second upcoming well and is a direct offset to the producing NOM-1H horizontal at the Company's Ripley leases. The well is slated to commence drilling in early September and will include a similar lateral targeting the newly discovered Mississippi reservoir.
As previously announced, American Petro-Hunter has locked in participation on an additional 11 horizontal wells at the Ripley Leases and the NOW-2H is the first of these to be drilled under the development program which is envisioned to involve the drilling of approximately one horizontal Mississippi well every 30 to 60 days. This judicious schedule would allow for a predictable time frame to drill, complete and emplace production facilities for both oil and gas sales every other month.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the UnitedStates Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
SCOTTSDALE, AZ � July 27, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to provide an outline of plans for the next two wells to be drilled at the Company's field development program at the North Oklahoma Project. These next wells in the series have been designated as NOS-2-22 and NOW-2H.
Preparations are now underway to commence drilling of the NOS-2-22 well with a scheduled spud date in approximately 2 weeks. The well is a direct offset to the producing NOS-1-22 well and has been engineered as a 3,500 foot vertical to exploit the productive oil bearing sand formation discovered in previous drilling. This is the first of potentially 3 offsets planned on this particular lease. With production facilities already in place, the drilling is hoped to add an additional 50 BPOD net to the Company by September. An exact spud date will be announced shortly.
The NOW-2H is scheduled as the second upcoming well and is a direct offset to the producing NOM-1H horizontal at the Company's Ripley leases. The well is slated to commence drilling in early September and will include a similar lateral targeting the newly discovered Mississippi reservoir.
As previously announced, American Petro-Hunter has locked in participation on an additional 11 horizontal wells at the Ripley Leases and the NOW-2H is the first of these to be drilled under the development program which is envisioned to involve the drilling of approximately one horizontal Mississippi well every 30 to 60 days. This judicious schedule would allow for a predictable time frame to drill, complete and emplace production facilities for both oil and gas sales every other month.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) showcase energy stock on Investorideas.com and energy portals and blogs (averages two thousand per month)
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) showcase energy stock on Investorideas.com and energy portals and blogs (averages two thousand per month)
Subscribe to:
Posts (Atom)